O=C1/C(=C\c2ccc([N+](=O)[O-])o2)SC2NC(COc3ccc(Cl)cc3)=NN12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?